H. Belgin Gülgeze

Orally Active Fusion Inhibitor of Respiratory Syncytial Virus

Christopher Cianci, Kuo‐Long Yu, Keith D. Combrink et al. · Antimicrobial Agents and Chemotherapy · 2004 · 140 citations · Full text

Pharmacy, Infectious Diseases, Medicinal Chemistry +17

Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability

Kuo‐Long Yu, Ny Sin, Rita L. Civiello et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 72 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

1,2-Benzisothiazol-3-one 1,1-Dioxide Inhibitors of Human Mast Cell Tryptase

Keith D. Combrink, H. Belgin Gülgeze, Nicholas A. Meanwell et al. · Journal of Medicinal Chemistry · 1998 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo

Ny Sin, Brian L. Venables, Keith D. Combrink et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 46 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo

Kuo‐Long Yu, Xiangdong Alan Wang, Rita L. Civiello et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 43 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13